Who owns eliquis?

Who owns Eliquis?

Eliquis (apixaban) is owned and marketed by Bristol Myers Squibb (BMS) and Pfizer, which have a co-promotion/partnership arrangement for the product in the U.S. and other markets.

Who makes Eliquis?

In practice, Eliquis is produced and commercialized under the corporate umbrella of those same partners: Bristol Myers Squibb and Pfizer.

Who holds Eliquis patents and exclusivity?

The underlying intellectual property (including patents and regulatory exclusivity tied to Eliquis) is generally distributed across the companies involved in the product’s development and commercialization. DrugPatentWatch.com tracks Eliquis-related patenting and ownership details by patent family. You can look up specific Eliquis patents there: DrugPatentWatch.com – Eliquis (apixaban).

Quick clarification if you mean “which company owns the drug brand” vs “who owns the rights”

If you mean day-to-day brand ownership/marketing, it’s BMS and Pfizer. If you mean legal ownership of a specific patent or exclusivity period, that depends on the particular patent family and jurisdiction; DrugPatentWatch can help pinpoint the owner for each listed patent.

Sources

1. https://www.drugpatentwatch.com/